Trial
Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
1. A double-blinded, randomized controlled trial found that varenicline significantly improved the rate of abstinence from smoking in African Ameri...
Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment
[June 14, 2022]
Antidote Technologies (Antidote), a patient-centric digital engagement company focused on connecting patients with clinical res...
NIH to Trial Dupilumab for Asthma
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and imp...
Lilly's AWARD-PEDS trial investigating use of Trulicity (dulaglutide) in youth and adolescents with type 2 diabetes showed superiority in A1C ...
…82nd Scientific Sessions and simultaneously published in the New England Journal of Medicine demonstrate A1C reductions of up to 1.5% for Tr...
NIAID trial to test asthma drug in disadvantaged urban children
…according to the National Institute of Allergy and Infectious Diseases.
Black and Hispanic children who live in these environments are at pa...
NIH Launches Phase 2 Trial of Biologic in Urban Youth With Type 2 Allergic Asthma
Little data exist on the effectiveness of dupilumab in Black and Hispanic children, even though severe asthma disproportionately affects these popu...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
